01 1ALEMBIC PHARMACEUTICALS LIMITED Vadodara IN
02 1CIPLA LIMITED Mumbai IN
03 1EMCURE PHARMACEUTICALS LIMITED Pune IN
04 1FORMOSA LABORATORIES, INC. Taoyuan TW
05 1MAPRIMED S.A. Buenos Aires AR
01 5Leflunomide
01 1Argentina
02 3India
03 1Taiwan
01 5Valid
Certificate Number : R1-CEP 2007-172 - Rev 02
Status : Valid
Issue Date : 2018-09-04
Type : Chemical
Substance Number : 2330
Certificate Number : R1-CEP 2007-050 - Rev 01
Status : Valid
Issue Date : 2014-07-28
Type : Chemical
Substance Number : 2330
Certificate Number : CEP 2018-269 - Rev 02
Status : Valid
Issue Date : 2024-09-11
Type : Chemical
Substance Number : 2330
Certificate Number : R1-CEP 2009-035 - Rev 01
Status : Valid
Issue Date : 2018-02-09
Type : Chemical
Substance Number : 2330
Certificate Number : R0-CEP 2018-252 - Rev 01
Status : Valid
Issue Date : 2022-10-27
Type : Chemical
Substance Number : 2330
45
PharmaCompass offers a list of Leflunomide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Leflunomide manufacturer or Leflunomide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Leflunomide manufacturer or Leflunomide supplier.
PharmaCompass also assists you with knowing the Leflunomide API Price utilized in the formulation of products. Leflunomide API Price is not always fixed or binding as the Leflunomide Price is obtained through a variety of data sources. The Leflunomide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]-, including repackagers and relabelers. The FDA regulates Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- supplier is an individual or a company that provides Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- active pharmaceutical ingredient (API) or Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- finished formulations upon request. The Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- suppliers may include Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- API manufacturers, exporters, distributors and traders.
click here to find a list of Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- CEP of the European Pharmacopoeia monograph is often referred to as a Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- Certificate of Suitability (COS). The purpose of a Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- to their clients by showing that a Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- CEP has been issued for it. The manufacturer submits a Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- CEP (COS) as part of the market authorization procedure, and it takes on the role of a Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- CEP holder for the record. Additionally, the data presented in the Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- DMF.
A Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- suppliers with CEP (COS) on PharmaCompass.
We have 5 companies offering Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]-
Get in contact with the supplier of your choice:
